Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Kurt E. Schaecher"'
Autor:
Thomas F. Scherr, Christina E. Douglas, Kurt E. Schaecher, Randal J. Schoepp, Keersten M. Ricks, Charles J. Shoemaker
Publikováno v:
Diagnostics, Vol 14, Iss 12, p 1290 (2024)
In recent years, infectious disease diagnosis has increasingly turned to host-centered approaches as a complement to pathogen-directed ones. The former, however, typically requires the interpretation of complex multiple biomarker datasets to arrive a
Externí odkaz:
https://doaj.org/article/645f33a44bec4291b3a466142361b66e
Autor:
Jeffrey R. Kugelman, Michael R. Wiley, Suzanne Mate, Jason T. Ladner, Brett Beitzel, Lawrence Fakoli, Fahn Taweh, Karla Prieto, Joseph W. Diclaro, Timothy Minogue, Randal J. Schoepp, Kurt E. Schaecher, James Pettitt, Stacey Bateman, Joseph Fair, Jens H. Kuhn, Lisa Hensley, Daniel J. Park, Pardis C. Sabeti, Mariano Sanchez-Lockhart, Fatorma K. Bolay, Gustavo Palacios
Publikováno v:
Emerging Infectious Diseases, Vol 21, Iss 7, Pp 1135-1143 (2015)
To support Liberia’s response to the ongoing Ebola virus (EBOV) disease epidemic in Western Africa, we established in-country advanced genomic capabilities to monitor EBOV evolution. Twenty-five EBOV genomes were sequenced at the Liberian Institute
Externí odkaz:
https://doaj.org/article/1fa2bbdcdee34b408df133dd69aae4aa
Autor:
M. Allison Arwady, Luke Bawo, Jennifer C. Hunter, Moses Massaquoi, Almea Matanock, Bernice Dahn, Patrick Ayscue, Tolbert G. Nyenswah, Joseph D. Forrester, Lisa Hensley, Benjamin Monroe, Randal J. Schoepp, Tai-Ho Chen, Kurt E. Schaecher, Thomas George, Edward Rouse, Ilana J. Schafer, Satish K. Pillai, Kevin M. De Cock
Publikováno v:
Emerging Infectious Diseases, Vol 21, Iss 4, Pp 578-584 (2015)
Over the span of a few weeks during July and August 2014, events in West Africa changed perceptions of Ebola virus disease (EVD) from an exotic tropical disease to a priority for global health security. We describe observations during that time of a
Externí odkaz:
https://doaj.org/article/03282272966d45f0961555aa7b9bdf31
Autor:
Kurt E. Schaecher, Martin G. Ottolini, Elena Crouch, Allison M. W. Malloy, Erin Jacobs, Jonathan Gonzalez, Margaret Kehl
Publikováno v:
Military Medicine. 186:76-81
Background Respiratory viruses are an important cause of nonbattle injury disease and contribute to the top seven reasons for medical encounters. In the absence of vaccines that provide complete protection against these viruses, viral surveillance ca
Autor:
Daniel Ewing, Kanakatte Raviprakash, Marvin J Sklar, Joan Godich, Melissa H. Knapp, Kerry Wilson, Kurt E. Schaecher, Gabriel Defang, Timothy J. Whitman, Karen B. Cromwell, Shannon Wood
Publikováno v:
American Journal of Infection Control
Objective To describe an outbreak of influenza A in an oncology unit, highlighting infection control methods implemented, and examining reasons health care workers (HCWs) present to work with influenza-like illness (ILI). Methods Confirmed cases were
Autor:
Sathish Rajamani, Kurt E. Schaecher, Reuel A Sandy, Jennifer N Dootz, Evan M Falcinelli, Allen J. Duplantier, Rekha G. Panchal, Malathy Krishnamurthy, Margaret M. Lemmon, Tiffany M Mott
Publikováno v:
Infection and Drug Resistance. 12:1393-1405
Purpose: The rapid emergence of multidrug-resistant (MDR) bacteria and the lack of new therapies to eliminate them poses a major threat to global health. With the alarming rise in antimicrobial resistance (AMR), focus has now shifted to the use of th
Autor:
Jason T Ladner, Sierra N Henson, Annalee S Boyle, Anna L Engelbrektson, Zane W Fink, Fatima Rahee, Jonathan D’ambrozio, Kurt E Schaecher, Mars Stone, Wenjuan Dong, Sanjeet Dadwal, Jianhua Yu, Michael A Caligiuri, Piotr Cieplak, Magnar Bjørås, Mona H Fenstad, Svein A Nordbø, Denis E Kainov, Norihito Muranaka, Mark S Chee, Sergey A Shiryaev, John A Altin
Publikováno v:
bioRxiv : the preprint server for biology.
A high-resolution understanding of the antibody response to SARS-CoV-2 is important for the design of effective diagnostics, vaccines and therapeutics. However, SARS-CoV-2 antibody epitopes remain largely uncharacterized, and it is unknown whether an
Autor:
Nancy C. Smith, Ann C. Ong, Jason Stam, Edwin Kamau, Mary Hinkle, Jack N. Hutter, Matthew S. Chorost, Kurt E. Schaecher, Patrick McGann
Publikováno v:
JMM Case Reports
Introduction. Microbacterium spp. are yellow-pigmented Gram-positive coryneform rods found in various environmental sources, such as soil and water samples. They rarely cause human infection, mostly infecting immunocompromised patients and catheter i
Autor:
Kurt E. Schaecher, Mars Stone, Sierra N. Henson, Wenjuan Dong, Norihito Muranaka, Sergey A. Shiryaev, Jonathan D'ambrozio, John A. Altin, Piotr Cieplak, Jianhua Yu, Mona H. Fenstad, Jason T. Ladner, Sanjeet Dadwal, Magnar Bjørås, Svein Arne Nordbø, Annalee S. Boyle, Michael A. Caligiuri, Anna Engelbrektson, Zane Fink, Mark S. Chee, Fatima Rahee, Denis E. Kainov
Publikováno v:
Cell Reports Medicine
bioRxiv
article-version (status) pre
article-version (number) 1
bioRxiv
article-version (status) pre
article-version (number) 1
The SARS-CoV-2 proteome shares regions of conservation with endemic human coronaviruses (CoVs), but it remains unknown to what extent these may be cross-recognized by the antibody response. Here, we study cross-reactivity using a highly multiplexed p
Autor:
Fahn Taweh, Jens H. Kuhn, Jeffrey R. Kugelman, Pardis C. Sabeti, Mariano Sanchez-Lockhart, Fatorma K. Bolay, Stacey L. Bateman, Joseph N. Fair, Michael R. Wiley, Daniel J. Park, Kurt E. Schaecher, Timothy D. Minogue, Randal J. Schoepp, Joseph W. Diclaro, James Pettitt, Karla Prieto, Suzanne Mate, Lawrence Fakoli, Jason T. Ladner, Gustavo Palacios, Brett Beitzel, Lisa E. Hensley
Publikováno v:
Emerging Infectious Diseases, Vol 21, Iss 7, Pp 1135-1143 (2015)
Emerging Infectious Diseases
Emerging Infectious Diseases
The effects of EBOV evolution on diagnostic assays and therapeutic drugs appear to be low.
To support Liberia’s response to the ongoing Ebola virus (EBOV) disease epidemic in Western Africa, we established in-country advanced genomic capabilit
To support Liberia’s response to the ongoing Ebola virus (EBOV) disease epidemic in Western Africa, we established in-country advanced genomic capabilit